유방암환자에서 수술 전 혈액구성 비율 및 수술 후 병리결과에 따른 재발과의 연관성
The Association With Recurrence in Breast Cancer Patients According to the Preoperative Blood Composition Ratio and Postoperative Pathological Results
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to determine the correlation between various clinical results, including recurrence in patients with breast cancer, and preoperative blood composition ratio and postoperative pathological results. Methods: A total of 444 patients who underwent surgery were included, and the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and postoperative pathological results were classified into postoperative cancer stages to confirm the association with various clinical results, including recurrence. Results: The median age of the patients was 51 years. The stages were divided into 1, 2, 3, and 4. Additionally, stages 1 and 2 comprised one group and stages 3 and 4 comprised another group. The cut-off values of the NLR, PLR, and MLR were confirmed to be 1.43, 158.84, and 0.21, respectively. It was noted that the association with recurrence was higher in the group with hormone receptor negative (p<0.001), higher stage (p<0.001), and underwent neoadjuvant chemotherapy (p<0.001). In the association with blood composition ratio and recurrence, survival was high in the PLR group with a high cut-off value (p=0.004). There was no significant relationship in the NLR and MLR groups. In the disease-free survival and overall-survival curves, only the PLR group showed a significant association of 0.003 and 0.001, respectively. The NLR and MLR groups did not show any significant result. Conclusion: No significant association with recurrence and mortality was confirmed in the NLR and MLR groups. However, the preoperative blood test in the high PLR group showed recurrence and mortality rate were high.
Abstract
Purpose: This study aimed to determine the correlation between various clinical results, including recurrence in patients with breast cancer, and preoperative blood composition ratio and postoperative pathological results. Methods: A total of 444 patients who underwent surgery were included, and the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and postoperative pathological results were classified into postoperative cancer stages to confirm the association with various clinical results, including recurrence. Results: The median age of the patients was 51 years. The stages were divided into 1, 2, 3, and 4. Additionally, stages 1 and 2 comprised one group and stages 3 and 4 comprised another group. The cut-off values of the NLR, PLR, and MLR were confirmed to be 1.43, 158.84, and 0.21, respectively. It was noted that the association with recurrence was higher in the group with hormone receptor negative (p<0.001), higher stage (p<0.001), and underwent neoadjuvant chemotherapy (p<0.001). In the association with blood composition ratio and recurrence, survival was high in the PLR group with a high cut-off value (p=0.004). There was no significant relationship in the NLR and MLR groups. In the disease-free survival and overall-survival curves, only the PLR group showed a significant association of 0.003 and 0.001, respectively. The NLR and MLR groups did not show any significant result. Conclusion: No significant association with recurrence and mortality was confirmed in the NLR and MLR groups. However, the preoperative blood test in the high PLR group showed recurrence and mortality rate were high.
참고문헌 (24)
- "Breast Cancer Facts & Figures v" (2020)[URL]
- 윤미란, "호르몬 수용체 약양성 유방암과 삼중음성 유방암의 치료 예후", Journal of Breast Disease, 7(1), pp.1~8 (2019), 한국유방암학회[DOI]
- Waks AG, "Breast cancer treatment : a review", JAMA, 321, pp.288~300 (2019)
- Vicente Conesa MA, "Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy", Breast, 21, pp.468~474 (2012)
- Hanahan D, "Hallmarks of cancer : the next generation", Cell, 144, pp.646~674 (2011)
- Mazaki J, "Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer : a propensity score analysis", BMC Cancer, 20, pp.922~ (2020)
- Corbeau I, "Neutrophil to lymphocyte ratio as prognostic and predictive factor in breast cancer patients : a systematic review", Cancers, 12, pp.958~ (2020)
- Tiainen S, "The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype", Breast Cancer Res Treat, 185, pp.63~72 (2021)
- Kim JY, "Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis", BMC Cancer, 20, pp.1206~ (2020)
- Hawley ST, "Recurrence risk perception and quality of life following treatment of breast cancer", Breast Cancer Res Treat, 161, pp.557~565 (2017)
- Wapnir IL, "Current strategies for the management of locoregional breast cancer recurrence", Oncology, 33, pp.19~25 (2019)
- Jaeyoon Kim, "Organ-Specific Recurrence or Metastatic Pattern of Breast Cancer according to Biological Subtypes and Clinical Characteristics", Journal of Breast Disease, 7(1), pp.30~37 (2019), 한국유방암학회[DOI]
- Merino T, "Risk factors for loco-regional recurrence in breast cancer patients : a retrospective study", Oncotarget, 9, pp.30355~30362 (2018)
- Schunkert EM, "Breast cancer recurrence risk assessment: is non-invasive monitoring an option?", Biomed Hub, 3, pp.1~17 (2018)
- Yoshinami T, "Detection of ctDNA with personalized molecular barcode NGS and its clinical significance in patients with early breast cancer", Transl Oncol, 13, pp.100787~ (2020)
- Asaoka M, "Neoadjuvant chemotherapy for breast cancer : past, present, and future", Breast Cancer, 14, pp.1178223420980377~ (2020)
- Shah C, "Advances in breast cancer radiotherapy : implications for current and future practice", JCO Oncol Pract, 17, pp.697~706 (2021)
- Lecot P, "Neutrophil heterogeneity in cancer : from biology to therapies", Front Immunol, 10, pp.2155~ (2019)
- Wu L, "Breast cancer cell-neutrophil interactions enhance neutrophil survival and pro-tumorigenic activities", Cancers, 12, pp.2884~ (2020)
- Gago-Dominguez M, "Neutrophil to lymphocyte ratio and breast cancer risk : analysis by subtype and potential interactions", Sci Rep, 10, pp.13203~ (2020)
- Ethier JL, "Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer : a systematic review and meta-analysis", Breast Cancer Res, 19, pp.2~ (2017)
- Schlesinger M, "Role of platelets and platelet receptors in cancer metastasis", J Hematol Oncol, 11, pp.125~ (2018)
- Graziano V, "Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients", Breast, 44, pp.33~38 (2019)
- Olingy CE, "Monocyte heterogeneity and functions in cancer", J Leukoc Biol, 106, pp.309~322 (2019)